Malignant Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s original application for a generic pemetrexed product.
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application for pemetrexed disodium, a generic version of pemetrexed for cancer indications.
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (BluePoint Laboratories)
The FDA approved BluePoint Laboratories' original application for a generic pemetrexed disodium product. This makes a pemetrexed disodium ge…
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (BluePoint Laboratories)
FDA approved a generic pemetrexed disodium product (PEMETREXED) from BluePoint Laboratories under an original ANDA.
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (Sagent Pharmaceuticals)
FDA approves an original generic application for pemetrexed disodium (Pemetrexed) by Sagent Pharmaceuticals. Pemetrexed is used in the treat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (BluePoint Laboratories)
FDA approved the original application for a generic version of pemetrexed disodium (PEMETREXED) from BluePoint Laboratories.
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (Waverley Pharma Inc)
FDA approved the original application for pemetrexed disodium (generic PEMETREXED) from Waverley Pharma Inc. This approval covers the drug's…
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' Original Application for a generic pemetrexed product (PEMETREXED), authorizing its manufacture and sal…
-
FDA approval · 2022-05-25FDA Approved: PEMETREXED — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original ANDA for pemetrexed disodium (generic pemetrexed), allowing marketing of a generic pemetrexe…
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma [Phase 3]
Phase 3 trial comparing Pembrolizumab immunotherapy to standard chemotherapy in advanced malignant pleural mesothelioma has completed with r…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial updates on MEDI4736 (durvalumab) alone or with tremelimumab in surgically resectable malignant pleural mesothelioma have compl…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent [Phase 2]
Phase 2 trial evaluating nintedanib in recurrent malignant pleural mesothelioma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase 1/2 trial investigating BBI608 with pemetrexed and cisplatin in malignant pleural mesothelioma and non-small cell lung cancer has comp…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating intracavitary cisplatin-fibrin localized chemotherapy after pleurectomy/decortication or extrapleural …
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [Phase 1, Phase 2]
Phase I/II trial evaluating CBP501 in combination with pemetrexed and cisplatin for malignant pleural mesothelioma; study completed with pos…
-
CLINICAL_TRIALS trial_result · 2021-07-14Clinical Trial Update: Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. [Phase 2]
Phase 2 trial update of lurbinectedin monotherapy in patients with progressive malignant pleural mesothelioma.
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients [Phase 2]
Phase 2 trial update evaluating nivolumab alone or with ipilimumab in unresectable malignant pleural mesothelioma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating neoadjuvant toripalimab plus chemotherapy for malignant pleural mesothelioma is ongoing; status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin [Phase 1, Phase 2]
Clinical trial updates on the combination of tivantinib with pemetrexed and carboplatin in malignant pleural mesothelioma and nonsquamous no…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating gemcitabine combined with imatinib mesylate in pemetrexed-pretreated malignant pleural mesothelioma completed.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial update investigating ipilimumab and nivolumab for malignant pleural mesothelioma has been completed.
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) [Phase 3]
Phase 3 trial comparing vorinostat (MK-0683) to placebo in advanced malignant pleural mesothelioma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase I safety lead-in followed by Phase II randomised study evaluating ONCOS-102 with pemetrexed/c cisplatin in unresectable malignant pleu…
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma [Phase 1]
Phase 1 trial evaluating safety and efficacy ofListeria-based therapy combined with chemotherapy as front-line treatment for malignant pleur…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Clinical study of YS110 in malignant pleural mesothelioma has completed Phase 1 and Phase 2.